Skip to main content
Evoke Pharma Inc logo

Evoke Pharma Inc — Investor Relations & Filings

Ticker · EVOK ISIN · US30049G2030 LEI · 529900Q01Z5E3L6MZZ66 US Manufacturing
Filings indexed 663 across all filing types
Latest filing 2025-12-30 Regulatory Filings
Country US United States of America
Listing US EVOK

About Evoke Pharma Inc

https://evokepharma.com/

Evoke Pharma, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs for gastrointestinal (GI) diseases. The company's primary focus is on addressing unmet medical needs in patients with diabetic gastroparesis, a chronic condition characterized by delayed gastric emptying. This condition can cause erratic absorption of oral medications, leading to inadequate symptom relief for issues like nausea, vomiting, and bloating. Evoke Pharma develops therapeutic approaches designed to provide a more reliable treatment option for patients who do not achieve adequate relief from conventional oral drugs.

Recent filings

Filing Released Lang Actions
15-12G
Regulatory Filings
2025-12-30 English
OWNERSHIP DOCUMENT
Director's Dealing
2025-12-19 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-12-19 English
Regulatory Filings 2025
Regulatory Filings
2025-12-19 English
Regulatory Filings 2025
Regulatory Filings
2025-12-19 English
Regulatory Filings 2025
Regulatory Filings
2025-12-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.